New hope for arthritis sufferers? CIT-013 drug trial begins
NCT ID NCT06567470
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new drug called CIT-013 in 88 adults with moderately active rheumatoid arthritis. Participants will receive either CIT-013 or a placebo every two weeks for six weeks. The goal is to see if CIT-013 reduces joint swelling and pain better than a placebo, and to check for any side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RHEUMATOID ARTHRITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
BE-02
WITHDRAWNAntwerp, Belgium
-
DE-01
RECRUITINGMünchen, Germany
Contact
-
DE-02
RECRUITINGMünchen, Germany
Contact
-
DE-03
WITHDRAWNRatingen, Germany
-
DE-04
RECRUITINGBamberg, Germany
Contact
-
DE-05
RECRUITINGBerlin, Germany
Contact
-
ES-01
RECRUITINGSantander, Spain
Contact
-
ES-02
RECRUITINGA Coruña, Spain
Contact
-
ES-03
RECRUITINGSantiago de Compostela, Spain
Contact
-
ES-04
RECRUITINGBarcelona, Spain
Contact
-
ES-05
RECRUITINGBarcelona, Spain
Contact
-
ES-06
RECRUITINGMadrid, Spain
Contact
-
NL-01
RECRUITINGRotterdam, Netherlands
Contact
-
NL-02
WITHDRAWNAmsterdam, Netherlands
-
NL-03
NOT_YET_RECRUITINGNijmegen, Netherlands
Contact
-
NL-04
WITHDRAWNLeiden, Netherlands
-
NL-05
RECRUITINGLeeuwarden, Netherlands
Contact
-
PL-01
RECRUITINGBialystok, Poland
Contact
-
PL-02
RECRUITINGPoznan, Poland
Contact
-
PL-03
RECRUITINGLublin, Poland
Contact
-
PL-04
RECRUITINGWarsaw, Poland
Contact
-
PL-05
RECRUITINGTorun, Poland
Contact
-
PL-07
RECRUITINGKrakow, Poland
Contact
-
Site BE-01
RECRUITINGLeuven, Belgium
Contact